MedPath
NMPA Approval

Montmorillonite Suspension

国药准字H20253808

April 8, 2025

Drug Information

蒙脱石混悬液

口服混悬剂

10克:3克

化学药品

April 8, 2025

Company Information

Applicant Company

四川省彭州工业开发区黄芩路168号5栋2楼

Manufacturing Company

四川省成都市双流区西南航空港经济开发区腾飞二路319号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

蒙脱石混悬液 - NMPA 批准文号 | MedPath